DR. PIERCING AFTERCARE MEDICATION- benzalkonium chloride spray

DR. PIERCING AFTERCARE MEDICATION by

Drug Labeling and Warnings

DR. PIERCING AFTERCARE MEDICATION by is a Otc medication manufactured, distributed, or labeled by Broadway Products LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

BENZALKONIUM CHLORIDE 0.11%

PURPOSE

ANTISEPTIC

USES

FOR CLEANING PIERCINGS AND MINOR WOUNDS.

DIRECTIONS

• TWIST THE CAP TO UNLOCK
• BEFORE USE, SPRAY IN AIR OR AWAY FROM WOUND TO TEST FLOW AND CLEAN NOZZLE HEAD
• TO APPLY, AIM NOZZLE AT AREA OF INTEREST FROM DESIRED DISTANCE AND SPRAY UNTIL DESIRED AMOUNT IS APPLIED

WARNINGS

• DO NOT USE IF TAMPER BAN IS REMOVED
• DO NOT USE IN BODY ORIFICES, EAR CANALAS OR EYES.
• CONSULT A HEALTHCARE PROFESSIONAL FOR CONTINUED WOUND CARE AND FOR USE ON CHILDREN
• IF SWELLING, REDNESS OR PAIN INCREASES, PLEASE SEEK THE ADVICE OF YOUR HEALTHCARE PROFESSIONAL
• STORE IN A COOL ENVIRONMENT AT 59 F TO 86 F AND PROTECTED FROM SUNLIGHT
• CONTENT UNDER PRESSURE
• FOR EXTERNAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

KEEP OUT OF REACH OF CHILDREN

OTHER INGREDIENTS

CAPB, ISOTONIC SALINE SOLUTION, SODIUM CHLORIDE, ALLANTOIN, ALOE VERA, KATHHOC CG II, PRO-VITAMIN B5, TRIETHANOLAMINE

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

DR. PIERCING AFTERCARE MEDICATION 
benzalkonium chloride spray

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 81926-101
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y)	BENZALKONIUM CHLORIDE	0.11 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
ISOTONIC SODIUM CHLORIDE SOLUTION (UNII: VR5Y7PDT5W)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
PANTOTHENIC ACID (UNII: 19F5HK2737)
TROLAMINE (UNII: 9O3K93S3TK)
COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)
ALLANTOIN (UNII: 344S277G0Z)
ALOE VERA LEAF (UNII: ZY81Z83H0X)
METHYLCHLOROISOTHIAZOLINONE/METHYLISOTHIAZOLINONE MIXTURE (UNII: 15O9QS218W)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 81926-101-74	74 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product	08/04/2022

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M003	08/04/2022

Labeler - Broadway Products LLC (002672936)